A 2016 paper exploring the biology of prostate cancer has been retracted due to figure manipulation.
According to the retraction notice, a reader contacted the journal Clinical Cancer Research in late 2016 with concerns that similar bands appeared multiple times in two images. The editors asked the paper’s corresponding author, Shahriar Koochekpour, about the issue and requested the raw data for the figures. But Koochekpour, based in the Departments of Cancer Genetics and Urology at Roswell Park Cancer Institute in Buffalo, New York, at the time of the study, could not locate the raw data.
Since the lab did not have raw data from such a relatively recent paper, the editors reached out to the research integrity officer at Roswell Park Cancer Institute to investigate. Indeed, the research integrity officer contacted confirmed that two figures were problematic, and requested the paper be retracted.
Here’s the rather detailed retraction notice, published in July 2017, for “GRM1 is An Androgen-Regulated Gene and its Expression Correlates with Prostate Cancer Progression in Pre-Clinical Models:” Continue reading “The article must be retracted:” Journal pulls prostate cancer study
The week at Retraction Watch featured the 

August 3rd is a big day around here — it’s our birthday. Today, we celebrate seven years since two science journalists decided, not exactly on whim but close to it, to launch a blog about retractions. Little did they know. (To hear our co-founder Ivan Oransky talk more about this milestone, check out his
Post-publication peer review isn’t just for scientists. Newspaper reporters can help correct the scientific record, too.
The author of a 2016 paper describing a potentially invaluable lab tool has retracted it, following heavy criticism from outside groups that could not reproduce the findings.
